cro.directory
← Compare landing

Ace Therapeutics vs Cyagen Biosciences

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAce TherapeuticsCyagen Biosciences
SummaryPreclinical CRO providing integrated research services including efficacy testing, disease model development, PK/PD, toxicology, biomarker research, and safety assessment across respiratory, ophthalmology, cardiovascular, and neurology therapeutic areas.Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.
ServicesData not yet provided.
  • Discovery Research
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Translational Research
ModalitiesData not yet provided.
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Neurology
  • Psychiatry
  • Cardiovascular
  • Respiratory
  • Ophthalmology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Rare Disease
  • Ophthalmology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
LocationsData not yet provided.
  • Headquarters, Santa Clara, California, United States
CertificationsData not yet provided.
  • AAALAC · Identifier: AAALAC-accredited facilities

Find similar companies

Ace Therapeutics alternatives · Cyagen Biosciences alternatives

Markdown mirror: /compare/ace-therapeutics/apac-cyagen.md